Find Brivudine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 69304-47-8, Bvdu, (e)-5-(2-bromovinyl)-2'-deoxyuridine, Brivudin, Helpin, Zostex
Molecular Formula
C11H13BrN2O5
Molecular Weight
333.13  g/mol
InChI Key
ODZBBRURCPAEIQ-PIXDULNESA-N
FDA UNII
2M3055079H

Brivudine
Brivudine is a uridine derivative and nucleoside analog with pro-apoptotic and chemosensitizing properties. In vitro, bromovinyl-deoxyuridine (BVDU) has been shown to downregulate the multifunctional DNA repair enzyme APEX nuclease 1, resulting in the inhibition of DNA repair and the induction of apoptosis. In addition, this agent may inhibit the expression of STAT3 (signal transducer and activator of transcription 3), which may result in the downregulation of vascular endothelial growth factor (VEGF). BVDU has also been found to inhibit the upregulation of chemoresistance genes (Mdr1 and DHFR) during chemotherapy. Overall, the gene expression changes associated with BVDU treatment result in the decrease or prevention of chemoresistance. In addition, this agent has been shown to enhance the cytolytic activity of NK-92 natural killer cells towards a pancreatic cancer cell line in vitro.
1 2D Structure

Brivudine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
2.1.2 InChI
InChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1
2.1.3 InChI Key
ODZBBRURCPAEIQ-PIXDULNESA-N
2.1.4 Canonical SMILES
C1C(C(OC1N2C=C(C(=O)NC2=O)C=CBr)CO)O
2.1.5 Isomeric SMILES
C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)CO)O
2.2 Other Identifiers
2.2.1 UNII
2M3055079H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (e)-5-(2-bromovinyl)-2'-deoxyuridine

2. (z)-5-(2-bromovinyl)-2'-deoxyuridine

3. 5-(2-bromoethenyl)-2'-deoxyuridine

4. 5-(2-bromovinyl)-2'-deoxyuridine

5. 5-bvdu

6. Brivudin

7. E-5-(2-bromovinyl)-durd

8. Z-5-(2-bromovinyl)-durd

9. Zostex

2.3.2 Depositor-Supplied Synonyms

1. 69304-47-8

2. Bvdu

3. (e)-5-(2-bromovinyl)-2'-deoxyuridine

4. Brivudin

5. Helpin

6. Zostex

7. Bromovinyldeoxyuridine

8. Brivudine [inn]

9. 5-bromovinyldeoxyuridine

10. (e)-5-(2-bromovinyl)-deoxyuridine

11. Rp101

12. Rp-101

13. Uridine, 5-[(1e)-2-bromoethenyl]-2'-deoxy-

14. Uridine, 5-(2-bromovinyl)-2'-deoxy-, (e)-

15. Brivudine (inn)

16. Nsc-633770

17. Ncgc00093656-01

18. 2m3055079h

19. 5-((e)-2-bromovinyl)-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione

20. Brivudinum

21. Brivudina

22. Brivudinum [inn-latin]

23. Brivudina [inn-spanish]

24. Mfcd00058585

25. 5-[(e)-2-bromoethenyl]-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

26. Bvd

27. Ccris 2831

28. 5-(2-bromovinyl)-2'-deoxyuridine

29. Nsc 633770

30. Trans-5-(2-bromovinyl)-2'-deoxyuridine

31. Bridic

32. Brivox

33. Zerpex

34. Brvdurd

35. Nsc633770

36. Unii-2m3055079h

37. Uridine, 5-(2-bromoethenyl)-2'-deoxy-, (e)-

38. Bv-durd

39. Zostex (tn)

40. (e)-5-(2-bromovinyl)-2-deoxyuridine

41. Brivudine [mi]

42. Brivudine [mart.]

43. Brivudine [who-dd]

44. Dsstox_cid_25755

45. Dsstox_rid_81098

46. Dsstox_gsid_45755

47. Lopac0_000175

48. Schembl99350

49. Chembl31634

50. Schembl141408

51. (e)-5-(2-bromovinyl)-durd

52. Dtxsid0045755

53. Zinc3653378

54. Tox21_111213

55. Bdbm50366681

56. S5009

57. Ua-618

58. Zb0745

59. E-5-(2-bromovinyl)-2'-deoxyuridine

60. Akos015833980

61. Ccg-204270

62. Cs-6292

63. Db03312

64. Lp00175

65. Sdccgsbi-0050163.p002

66. Ncgc00093656-02

67. 5-[(e)-2-bromoethenyl]-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

68. 5-[(e)-2-bromovinyl]-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione

69. As-35234

70. Hy-13578

71. 5-[(e)-2-bromoethenyl]-2'-deoxyuridine

72. Cas-69304-47-8

73. A-176

74. B3404

75. Eu-0100175

76. B 9647

77. D07249

78. 5-((e)-2-bromovinyl)-2'-deoxyuridine

79. Q904107

80. Sr-01000075726

81. J-700153

82. Sr-01000075726-1

83. Bromovinyldeoxyuridine; 5-[(e)-2-bromoethenyl]-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 333.13 g/mol
Molecular Formula C11H13BrN2O5
XLogP3-0.4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass332.00078 g/mol
Monoisotopic Mass332.00078 g/mol
Topological Polar Surface Area99.1 Ų
Heavy Atom Count19
Formal Charge0
Complexity450
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


4.2 ATC Code

J - Antiinfectives for systemic use

J05 - Antivirals for systemic use

J05A - Direct acting antivirals

J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors

J05AB15 - Brivudine


Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Brivudine

About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...

Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in the Indian state of Tamil Nadu. Nuray’s expertise and experience lie in developing the chemistry requirements of the pharmaceutical industry, including the synthesis of NCEs, impurities, metabolites, method development, advanced intermediates and APIs for commercial launch. With its focus on maintaining the highest levels of quality, reliability and transparency, Nuray has emerged as a trusted partner in the global generic market.
Nuray Chemicals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Flag India
Digital Content Digital Content

Brivudine

About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...

Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
Cohance

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Brivudine

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Brivudine

About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Brivudine

About the Company : Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with...

Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals. At Aurore, we aim to push the boundaries to manufacture and deliver high quality products that can be relied upon by both customers and regulators. Our thrust on rapidly adding capabilities have led us to acquire, integrate and expand our reach across the geographies.
blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

brivudine

About the Company : CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane) is a pharmaceuticals company with 75 years of brilliant history. Formerly known as Beijing Pha...

CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane) is a pharmaceuticals company with 75 years of brilliant history. Formerly known as Beijing Pharmaceuticals Factory, the company was listed on Shanghai Stock Exchange in 1997 with Stock Code as 600062. In 2010, it was merged into China Resources (Group) Co, Ltd. which is one of the Global 500 companies and became the main manufacturer of chemical medicines under the Group. In 2012, the company was officially renamed from Beijing Double-Crane Pharmaceuticals Co., Ltd. to CR Double-Crane Pharmaceuticals Co., Ltd.
blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Brivudine

About the Company : Hunan Warrant Pharmaceutical Co., Ltd. is a high-tech joint-stock company founded in 2001. With 3 production bases and 2 R&D center, which is engaged in manufacture & supply of API...

Hunan Warrant Pharmaceutical Co., Ltd. is a high-tech joint-stock company founded in 2001. With 3 production bases and 2 R&D center, which is engaged in manufacture & supply of APIs and Intermediates, Solid Dosage Formulations, Herbal Extracts, most of the APIs and all formulation production lines are new GMP certified. Hunan Warrant Chiral Pharmaceutical Co., Ltd. belongs to Hunan Warrant Parmaceutical Co., located in Ltd. & occupies more than 70 000 square meters, Tongguan Circuliar Economy Industrial Park in Wangcheng. It is a CFDA approved pharmaceutical company, focusing on the APIs & advanced intermediates manufacturing in China.
blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Brivudine

About the Company : Haorui, established in 1997, is a manufacturer and supplier of APIs, intermediates, veterinary and food additives. Meanwhile, it is assisting global pharmaceutical companies to get...

Haorui, established in 1997, is a manufacturer and supplier of APIs, intermediates, veterinary and food additives. Meanwhile, it is assisting global pharmaceutical companies to get the domestic registration of their finished dosage for their international expansion. Our USFDA approved products Flumazenil, Granisetron HCl, Granisetron Base, Docetaxel Anhydrous, Irinotecan HCl, Dasatinib Monohydrate, Oxaliplatin and Temozolomide have been recognized by our customers globally. In addition, our Amisulpride API acquired CEP, UK GMP & USDMF.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 69304-47-8 / Brivudine API manufacturers, exporters & distributors?

Brivudine manufacturers, exporters & distributors 1

95

PharmaCompass offers a list of Brivudine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brivudine manufacturer or Brivudine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brivudine manufacturer or Brivudine supplier.

PharmaCompass also assists you with knowing the Brivudine API Price utilized in the formulation of products. Brivudine API Price is not always fixed or binding as the Brivudine Price is obtained through a variety of data sources. The Brivudine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Brivudine

Synonyms

69304-47-8, Bvdu, (e)-5-(2-bromovinyl)-2'-deoxyuridine, Brivudin, Helpin, Zostex

Cas Number

69304-47-8

Unique Ingredient Identifier (UNII)

2M3055079H

About Brivudine

Brivudine is a uridine derivative and nucleoside analog with pro-apoptotic and chemosensitizing properties. In vitro, bromovinyl-deoxyuridine (BVDU) has been shown to downregulate the multifunctional DNA repair enzyme APEX nuclease 1, resulting in the inhibition of DNA repair and the induction of apoptosis. In addition, this agent may inhibit the expression of STAT3 (signal transducer and activator of transcription 3), which may result in the downregulation of vascular endothelial growth factor (VEGF). BVDU has also been found to inhibit the upregulation of chemoresistance genes (Mdr1 and DHFR) during chemotherapy. Overall, the gene expression changes associated with BVDU treatment result in the decrease or prevention of chemoresistance. In addition, this agent has been shown to enhance the cytolytic activity of NK-92 natural killer cells towards a pancreatic cancer cell line in vitro.

Zostex Manufacturers

A Zostex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zostex, including repackagers and relabelers. The FDA regulates Zostex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zostex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Zostex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Zostex Suppliers

A Zostex supplier is an individual or a company that provides Zostex active pharmaceutical ingredient (API) or Zostex finished formulations upon request. The Zostex suppliers may include Zostex API manufacturers, exporters, distributors and traders.

click here to find a list of Zostex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Zostex WC

A Zostex written confirmation (Zostex WC) is an official document issued by a regulatory agency to a Zostex manufacturer, verifying that the manufacturing facility of a Zostex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zostex APIs or Zostex finished pharmaceutical products to another nation, regulatory agencies frequently require a Zostex WC (written confirmation) as part of the regulatory process.

click here to find a list of Zostex suppliers with Written Confirmation (WC) on PharmaCompass.

Zostex GMP

Zostex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Zostex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zostex GMP manufacturer or Zostex GMP API supplier for your needs.

Zostex CoA

A Zostex CoA (Certificate of Analysis) is a formal document that attests to Zostex's compliance with Zostex specifications and serves as a tool for batch-level quality control.

Zostex CoA mostly includes findings from lab analyses of a specific batch. For each Zostex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Zostex may be tested according to a variety of international standards, such as European Pharmacopoeia (Zostex EP), Zostex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zostex USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty